Cargando…
Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient
Unlike immunocompetent hosts, the duration of viral persistence after infection with severe acute respiratory syndrome coronavirus 2 can be prolonged in immunosuppressed patients. Here, we present a case of viral persistence for over 19 weeks in a patient with a history of solid organ transplant and...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813887/ https://www.ncbi.nlm.nih.gov/pubmed/34510730 http://dx.doi.org/10.1111/ajt.16837 |
_version_ | 1784644957435330560 |
---|---|
author | Purpura, Lawrence J. Chang, Michelle Annavajhala, Medini K. Mohri, Hiroshi Liu, Lihong Shah, Jayesh Cantos, Anyelina Medrano, Nicola Laracy, Justin Scully, Brian Miko, Benjamin A. Habal, Marlena Pereira, Marcus R. Tsuji, Moriya Ho, David D. Uhlemann, Anne-Catrin Yin, Michael T. |
author_facet | Purpura, Lawrence J. Chang, Michelle Annavajhala, Medini K. Mohri, Hiroshi Liu, Lihong Shah, Jayesh Cantos, Anyelina Medrano, Nicola Laracy, Justin Scully, Brian Miko, Benjamin A. Habal, Marlena Pereira, Marcus R. Tsuji, Moriya Ho, David D. Uhlemann, Anne-Catrin Yin, Michael T. |
author_sort | Purpura, Lawrence J. |
collection | PubMed |
description | Unlike immunocompetent hosts, the duration of viral persistence after infection with severe acute respiratory syndrome coronavirus 2 can be prolonged in immunosuppressed patients. Here, we present a case of viral persistence for over 19 weeks in a patient with a history of solid organ transplant and explore the clinical, virologic, and immunologic course. Our patient still demonstrated viral persistence at 138 days with low polymerase chain reaction cycle threshold values and evidence of continuing viral sequence evolution indicative of ongoing virus replication. These findings have important implications for infection prevention and control recommendations in immunosuppressed patients. Immune response, including neutralizing antibody titers, T cell activity, and cytokine levels, peaked around days 44–72 after diagnosis. Anti-S trimer antibodies were low at all time points, and T cell response was attenuated by day 119. As immune response waned and viral load increased, increased genetic diversity emerged, suggesting a mechanism for the development of viral variants. |
format | Online Article Text |
id | pubmed-8813887 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88138872023-02-01 Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient Purpura, Lawrence J. Chang, Michelle Annavajhala, Medini K. Mohri, Hiroshi Liu, Lihong Shah, Jayesh Cantos, Anyelina Medrano, Nicola Laracy, Justin Scully, Brian Miko, Benjamin A. Habal, Marlena Pereira, Marcus R. Tsuji, Moriya Ho, David D. Uhlemann, Anne-Catrin Yin, Michael T. Am J Transplant Case Report Unlike immunocompetent hosts, the duration of viral persistence after infection with severe acute respiratory syndrome coronavirus 2 can be prolonged in immunosuppressed patients. Here, we present a case of viral persistence for over 19 weeks in a patient with a history of solid organ transplant and explore the clinical, virologic, and immunologic course. Our patient still demonstrated viral persistence at 138 days with low polymerase chain reaction cycle threshold values and evidence of continuing viral sequence evolution indicative of ongoing virus replication. These findings have important implications for infection prevention and control recommendations in immunosuppressed patients. Immune response, including neutralizing antibody titers, T cell activity, and cytokine levels, peaked around days 44–72 after diagnosis. Anti-S trimer antibodies were low at all time points, and T cell response was attenuated by day 119. As immune response waned and viral load increased, increased genetic diversity emerged, suggesting a mechanism for the development of viral variants. American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2022-02 2022-12-30 /pmc/articles/PMC8813887/ /pubmed/34510730 http://dx.doi.org/10.1111/ajt.16837 Text en Copyright © 2022 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Case Report Purpura, Lawrence J. Chang, Michelle Annavajhala, Medini K. Mohri, Hiroshi Liu, Lihong Shah, Jayesh Cantos, Anyelina Medrano, Nicola Laracy, Justin Scully, Brian Miko, Benjamin A. Habal, Marlena Pereira, Marcus R. Tsuji, Moriya Ho, David D. Uhlemann, Anne-Catrin Yin, Michael T. Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient |
title | Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient |
title_full | Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient |
title_fullStr | Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient |
title_full_unstemmed | Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient |
title_short | Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient |
title_sort | prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813887/ https://www.ncbi.nlm.nih.gov/pubmed/34510730 http://dx.doi.org/10.1111/ajt.16837 |
work_keys_str_mv | AT purpuralawrencej prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT changmichelle prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT annavajhalamedinik prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT mohrihiroshi prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT liulihong prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT shahjayesh prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT cantosanyelina prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT medranonicola prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT laracyjustin prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT scullybrian prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT mikobenjamina prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT habalmarlena prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT pereiramarcusr prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT tsujimoriya prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT hodavidd prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT uhlemannannecatrin prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient AT yinmichaelt prolongedsevereacuterespiratorysyndromecoronavirus2persistenceattenuatedimmunologicresponseandviralevolutioninasolidorgantransplantpatient |